| __timestamp | AbbVie Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 7724000000 | 5078000000 |
| Thursday, January 1, 2015 | 6387000000 | 4717000000 |
| Friday, January 1, 2016 | 5855000000 | 5096000000 |
| Sunday, January 1, 2017 | 6275000000 | 4986000000 |
| Monday, January 1, 2018 | 7399000000 | 4214000000 |
| Tuesday, January 1, 2019 | 6942000000 | 3806000000 |
| Wednesday, January 1, 2020 | 11299000000 | 3671000000 |
| Friday, January 1, 2021 | 12349000000 | 3528000000 |
| Saturday, January 1, 2022 | 15260000000 | 3445000000 |
| Sunday, January 1, 2023 | 12872000000 | 3498000000 |
| Monday, January 1, 2024 | 0 | 3702000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. This analysis compares the SG&A expenses of AbbVie Inc. and Teva Pharmaceutical Industries Limited from 2014 to 2023. AbbVie, a leader in the biopharmaceutical sector, has seen its SG&A expenses grow by approximately 66% over this period, peaking in 2022. In contrast, Teva, a major player in generic drugs, experienced a 32% decline in SG&A expenses, reflecting strategic cost-cutting measures. Notably, AbbVie's expenses surged in 2020, coinciding with its acquisition of Allergan, while Teva's expenses have steadily decreased since 2016. This divergence highlights differing strategic priorities: AbbVie's investment in growth versus Teva's focus on efficiency. Understanding these trends offers valuable insights into the financial strategies of these industry titans.
AbbVie Inc. vs Zoetis Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: AbbVie Inc. vs Intra-Cellular Therapies, Inc.
AbbVie Inc. and ACADIA Pharmaceuticals Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Xencor, Inc.
Cost Management Insights: SG&A Expenses for Gilead Sciences, Inc. and Teva Pharmaceutical Industries Limited
Comparing SG&A Expenses: Zoetis Inc. vs Teva Pharmaceutical Industries Limited Trends and Insights
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs Catalent, Inc.
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs BioMarin Pharmaceutical Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Teva Pharmaceutical Industries Limited and Opthea Limited
Teva Pharmaceutical Industries Limited or Alkermes plc: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Perrigo Company plc
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.